Semler Scientific Inc. (NASDAQ:SMLR - Get Free Report) shares rose 8% on Thursday . The company traded as high as $46.50 and last traded at $45.69. Approximately 400,454 shares changed hands during trading, a decline of 29% from the average daily volume of 560,628 shares. The stock had previously closed at $42.32.
Analysts Set New Price Targets
SMLR has been the topic of a number of research analyst reports. Maxim Group raised shares of Semler Scientific to a "strong-buy" rating and set a $95.00 price objective on the stock in a report on Wednesday. Benchmark initiated coverage on shares of Semler Scientific in a report on Tuesday, July 8th. They set a "buy" rating and a $101.00 price objective on the stock. Finally, Wall Street Zen lowered shares of Semler Scientific from a "buy" rating to a "sell" rating in a report on Thursday, May 22nd.
View Our Latest Stock Analysis on Semler Scientific
Semler Scientific Stock Performance
The company has a debt-to-equity ratio of 0.59, a current ratio of 0.52 and a quick ratio of 0.51. The company has a market capitalization of $623.21 million, a PE ratio of -17.44 and a beta of 1.39. The firm's fifty day simple moving average is $37.47 and its 200 day simple moving average is $41.86.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings results on Tuesday, May 13th. The company reported ($0.76) EPS for the quarter. Semler Scientific had a negative net margin of 60.69% and a positive return on equity of 19.75%. The business had revenue of $8.84 million during the quarter.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of SMLR. Kovitz Investment Group Partners LLC grew its position in shares of Semler Scientific by 2.2% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 22,885 shares of the company's stock valued at $1,236,000 after acquiring an additional 501 shares during the period. NewEdge Advisors LLC raised its holdings in Semler Scientific by 318.3% in the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock worth $40,000 after purchasing an additional 557 shares during the period. BNP Paribas Financial Markets acquired a new position in Semler Scientific in the 4th quarter worth about $30,000. Cambridge Investment Research Advisors Inc. raised its holdings in Semler Scientific by 10.2% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 6,226 shares of the company's stock worth $225,000 after purchasing an additional 576 shares during the period. Finally, SBI Securities Co. Ltd. raised its holdings in Semler Scientific by 161.3% in the 1st quarter. SBI Securities Co. Ltd. now owns 959 shares of the company's stock worth $35,000 after purchasing an additional 592 shares during the period. Institutional investors and hedge funds own 49.37% of the company's stock.
Semler Scientific Company Profile
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
